foto
VIEW OUR WEB SEMINARS
LATEST NEWS

OctoPlus publishes prospectus for listing of shares issued on 18 December 2009



HALF-YEAR RESULTS: 6 AUGUST

Click here to go to the webcast of OctoPlus' half-year results on Thursday 6 August at 10 AM CET



ANNUAL REPORT 2008

Click here to directly access OctoPlus' Annual Report 2008



GMP EXPANSION

OctoPlus has increased its fill & finish capacity by expanding its GMP facility



OCTO SHARE PRICE
HOME dashNL dash CONTACT

 

OVERVIEW

Contract pharmaceutical development and clinical trial material manufacturing

Founded in 1995, OctoPlus has built up a wealth of expertise in the pharmaceutical development of conventional and biotech-derived pharmaceuticals.

OctoPlus develops dosage forms enabling the administration of new medicines to patients. We cover this process from lab bench to clinical batches.

We have helped our partners bring more than 40 products into the clinic or to the market and are globally recognized as a center of excellence in formulation development, analytical services and small scale cGMP manufacturing.

All OctoPlus work is performed in our dedicated facilities in the Bioscience Park in Leiden, the Netherlands, where we operate a cGMP production area with dedicated areas for filling and finishing of sterile dosage forms. Our facilities comply with EU and FDA regulations and are regularly audited by our partners.